These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

322 related articles for article (PubMed ID: 6818930)

  • 41. Emergence of highly antibiotic-resistant Pseudomonas aeruginosa in relation to duration of empirical antipseudomonal antibiotic treatment.
    Philippe E; Weiss M; Shultz JM; Yeomans F; Ehrenkranz NJ
    Clin Perform Qual Health Care; 1999; 7(2):83-7. PubMed ID: 10747571
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Morphological study of the organs and tissues of mice infected after a burn with a Pseudomonas aeruginosa strain and treated with a Pseudomonas aeruginosa polyvalent corpuscular vaccine and tobramycin].
    Moroz AF; Kharitonova AM; Chanturiia TsK
    Antibiotiki; 1983 May; 28(5):341-5. PubMed ID: 6410985
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Pseudomonas pyocyanea infections in otorhinolaryngology].
    Nicoucar GR
    Pract Otorhinolaryngol (Basel); 1969; 31(6):359-64. PubMed ID: 4314671
    [No Abstract]   [Full Text] [Related]  

  • 44. Vaccines and immunotherapy against Pseudomonas aeruginosa.
    Döring G; Pier GB
    Vaccine; 2008 Feb; 26(8):1011-24. PubMed ID: 18242792
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Pseudomonas aeruginosa antibodies in patients with cystic fibrosis: clinical implications].
    Marianelli L; Campana S; Taccetti G; Gabbrielli M; Dei R
    Pediatr Med Chir; 1994; 16(6):551-4. PubMed ID: 7708538
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Early aggressive eradication therapy for intermittent Pseudomonas aeruginosa airway colonization in cystic fibrosis patients: 15 years experience.
    Hansen CR; Pressler T; Høiby N
    J Cyst Fibros; 2008 Nov; 7(6):523-30. PubMed ID: 18693078
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Dynamics of humoral antibody formation against the O-antigen of Pseudomonas aeruginosa in suppurative diseases].
    Zarubina EK; Svetukhin AM; Edvabnaia LS
    Khirurgiia (Mosk); 1980 Nov; (11):47-52. PubMed ID: 6777579
    [No Abstract]   [Full Text] [Related]  

  • 48. Antimicrobial susceptibility of Pseudomonas aeruginosa isolates obtained from patients in Canadian intensive care units as part of the Canadian National Intensive Care Unit study.
    Walkty A; Decorby M; Nichol K; Mulvey MR; Hoban D; Zhanel G;
    Diagn Microbiol Infect Dis; 2008 Jun; 61(2):217-21. PubMed ID: 18304774
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Trend of therapy in Pseudomonas aeruginosa infections].
    Jannuzzi C; Tassara A
    G Mal Infett Parassit; 1971 Nov; 23(11):1051-4. PubMed ID: 5004852
    [No Abstract]   [Full Text] [Related]  

  • 50. [Postoperative infections due to Pseudomonas aeruginosa].
    Ishikawa S; Yura J
    Nihon Rinsho; 1991 Oct; 49(10):2336-41. PubMed ID: 1721097
    [No Abstract]   [Full Text] [Related]  

  • 51. Clinical, microbiologic, and epidemiologic characteristics of Pseudomonas aeruginosa infections in a University Hospital, Malatya, Turkey.
    Yetkin G; Otlu B; Cicek A; Kuzucu C; Durmaz R
    Am J Infect Control; 2006 May; 34(4):188-92. PubMed ID: 16679175
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Prevention of pseudomonas respiratory infection in a surgical intensive care unit.
    Polk HC; Borden S; Aldrete JA
    Ann Surg; 1973 May; 177(5):607-15. PubMed ID: 4634109
    [No Abstract]   [Full Text] [Related]  

  • 53. [Epidemiology of pseudomonas infections].
    Nezval J
    Zentralbl Bakteriol Orig; 1968 Feb; 206(1):86-92. PubMed ID: 4311499
    [No Abstract]   [Full Text] [Related]  

  • 54. Pseudomonas aeruginosa sepsis with ecthyma gangrenosum and pseudomembranous pharyngolaryngitis in a 5-month-old boy.
    Fang LC; Peng CC; Chi H; Lee KS; Chiu NC
    J Microbiol Immunol Infect; 2014 Apr; 47(2):158-61. PubMed ID: 22727891
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Emergence of ciprofloxacin-resistant pseudomonas in chronic suppurative otitis media.
    Jang CH; Park SY
    Clin Otolaryngol Allied Sci; 2004 Aug; 29(4):321-3. PubMed ID: 15270816
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Antimicrobial resistance among clinical isolates of Pseudomonas aeruginosa from patients in a teaching hospital, Riyadh, Saudi Arabia, 2001-2005.
    Babay HA
    Jpn J Infect Dis; 2007 May; 60(2-3):123-5. PubMed ID: 17515646
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Letter: Pseudomonas aeruginosa orchitis and untimely antibiotic therapy].
    Couinaud C; Koechlin P
    Nouv Presse Med; 1975 Jan; 4(1):34. PubMed ID: 806895
    [No Abstract]   [Full Text] [Related]  

  • 58. [Active drugs against Pseudomonas aeruginosa and their clinical usefulness].
    Gobernado M
    Rev Clin Esp; 1998 Sep; 198 Suppl 2():51-61. PubMed ID: 9844479
    [No Abstract]   [Full Text] [Related]  

  • 59. Efficacy and safety of colistin (colistimethate sodium) for therapy of infections caused by multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii in Siriraj Hospital, Bangkok, Thailand.
    Koomanachai P; Tiengrim S; Kiratisin P; Thamlikitkul V
    Int J Infect Dis; 2007 Sep; 11(5):402-6. PubMed ID: 17291803
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Study of the immunogenicity of the Pseudomonas aeruginosa polyvalent corpuscular vaccine in human volunteers.
    Meitert E; Meitert T; Petrovici M; Sima F; Savulian C; Mitrică N; Georgescu C; Costache G
    Arch Roum Pathol Exp Microbiol; 1979; 38(3-4):309-16. PubMed ID: 122593
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.